Organon Dermatology to present new Phase 3 analysis of VTAMA eczema data at the Society for Pediatric Dermatology annual meeting on July 23, 2026.

Opposition to AI infrastructure is crystallizing into a political force — the likes of which this province has seen before.

Turn Therapeutics, Inc. (NASDAQ: TTRX), a clinical-stage biotechnology company developing targeted, non-systemic therapies for inflammatory skin diseases, today announced the completion of a ...

DEED says paid leave use appears “steady”, but officials won’t announce potential premium rate changes for 2027 until the end ...

More than 250 natural gas and LNG industry professionals are expected to gather for market insights, networking, and commercial discussions across the U.S. Rockies and West energy value chain LDC Gas ...

Autonomous security company Assail Inc. today launched Sidewinder, a rebuilt version of its Ares offensive security platform ...

GS Retail held an AI transformation (AX) case-sharing event at GS Tower in Seoul's Yeoksam district on Monday, bringing ...

UCSD establishes Institute for Applied Health Intelligence UC San Diego recently announced the establishment of the Institute ...

Canada's new national power strategy creates huge investment opportunities for grids and clean power while loosening ...

Discusses AI Solutions, Product Advancements, and Strategic Opportunities in Data Transformation July 7, 2026 3:00 PM ...

Scientists and advocates worry the state’s predator control gamble will fail but still expand aerial bear gunning across ...